21 May 2009
A comparison of transplant outcomes in peritoneal and hemodialysis patients – a paired kidney analysis
A Dębska-Ślizień, W Wołyniec, , G Moszkowska, D Zadrozny, A Milecka, B RutkowskiAnn Transplant 2009; 14(1): 26-26 :: ID: 880293
Abstract
Background: Studies examining the effect of pre-transplant dialysis modality on graft and patient survival have given confl icting results. Therefore, we studied the effects of pre-transplant dialysis modality on the transplantation outcome. To minimize the donor variability and bias, a paired kidney analysis was used.
Material/Methods: From December 1994 to December 2005, 69 peritoneal dialysis (PD) (31 m, 48 f) patients received transplantation. PD constituted 12% of all kidney transplantations performed in our centre at that time. 50/69 PD patients (27 m, 23 f) aged from 14 to 64 (mean 39.9±12.4) years had their haemodialysis (HD) pair (34 m, 16 f) aged from 16 to 69 (mean 42.6±11.5) years.
Results: Studied groups (PD vs. HD) differed significantly with respect to duration of RRT before transplantation (19.7±20.4 vs. 35.5±50.7; p<0.05) months. The groups (PD vs. HD) did not differ significantly with respect to: number of mismatches, type of immunosuppressive protocol, one year patient survival (96% vs. 100%), and one-year graft survival (86% vs. 86%). PD vs. HD had lower incidence of delayed graft function (18% vs. 46%; p< 0.05) and acute rejection (22% vs. 30%), graft thrombosis was more commonly listed as a cause of graft failure in PD group, also all types of infections occurred more
frequently in PD patients (44% vs. 32%). Graft function estimated one year after transplantation applying creatinine concentration was similar in PD vs. HD group (1.57 mg/dl vs. 1.61 mg/dl). Conclusions. The outcome of RT is similar in patients coming from either PD or HD. Delayed graft function was less common in PD patients but this potential benefit appears to be counter-balanced by other factors with are associated with the graft loss
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






